The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence and influence on outcome of Neuregulin- (NRG1), HER2/neu- and HER3- expression in patients with metastatic colorectal cancer (mCRC) treated with irinotecan-based first-line regimens (FUFIRI vs. mIROX) in the FIRE 1-trial.
 
Arndt Stahler
No Relationships to Disclose
 
Volker Heinemann
No Relationships to Disclose
 
Clemens Albrecht Giessen
No Relationships to Disclose
 
Andreas Schalhorn
No Relationships to Disclose
 
Sebastian Stintzing
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Ursula Vehling-Kaiser
No Relationships to Disclose
 
Martina Stauch
No Relationships to Disclose
 
Detlef Quietzsch
No Relationships to Disclose
 
Jens Neumann
No Relationships to Disclose
 
Thomas Kirchner
Honoraria - Amgen, Merck-Serono, Roche, Astra-Zeneca
Consulting or Advisory Role - Amgen, Merck-Serono, Roche, Astra-Zeneca
Research Funding - Roche
 
Andreas Jung
No Relationships to Disclose
 
Dominik Paul Modest
No Relationships to Disclose